Determining mechanisms of innate immune modulation by ADP-ribosylation
通过 ADP-核糖基化确定先天免疫调节机制
基本信息
- 批准号:10386112
- 负责人:
- 金额:$ 3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:ADP Ribose TransferasesADP ribosylationAddressAdenosine Diphosphate RiboseAffectAntiviral AgentsAntiviral ResponseAntiviral TherapyAutomobile DrivingBiological ProcessBiologyCell Culture TechniquesCellsChiropteraCommunicable DiseasesCoronavirusFamilyFoundationsGoalsHydrolaseHypersensitivityImmune responseImpairmentInfectionInnate Immune ResponseInterferonsKnock-outKnowledgeLeadMalignant NeoplasmsMediatingMissionModelingMurine hepatitis virusNational Institute of General Medical SciencesPathway interactionsPhenotypePhosphorylationPost-Translational Protein ProcessingProcessProteinsRNA replicationResearchResearch PersonnelRoleSystemTogaviridaeTranslationsViralViral hepatitisVirusVirus DiseasesVirus ReplicationWorkhuman diseaseimmunoregulationinhibitor/antagonistinnate immune mechanismsinnovationmutantnovelpathogenic virusprotein functionresponse
项目摘要
PROJECT SUMMARY
ADP-ribosylation is an important post-translational modification that directly influences several
biological processes including cancer, allergy, and infectious disease. ADP-ribose can be added to proteins as
one or more consecutive units by ADP-ribosyltransferases, also termed PARPs, resulting in mono- or poly-
ADP-ribosylation (mAR or pAR). Most mARylating PARPs are upregulated by interferon (IFN) upon virus
infection and several are predicted to have antiviral functions. In addition, several viral families, including the
Coronaviridae and Togaviridae, encode for macrodomain proteins that have mono-ADP-ribosyl hydrolase
(ARH) activity. This activity allows these viruses the ability to specifically counteract the effects of mAR, further
implicating mAR in the mammalian antiviral response. Despite these findings, there are only a few known
examples where mAR is known to inhibit virus replication. This is largely due to the lack of cell culture models
of virus infections where the mAR status of a cell can be specifically controlled, such as models using mutant
viruses or PARP knockout cells that have significant phenotypes. Importantly, the PI has established a virus
infection system using a model coronavirus, Murine Hepatitis Virus (MHV), where virus lacking ARH activity is
i) significantly impaired in virus replication and ii) independently induces a robust IFN response. These
phenotypes are reversed by PARP inhibitors, establishing mAR as a key factor driving this anti-viral response.
The investigator’s long-term goal is to determine mechanistically how mAR inhibits virus replication and
enhances the innate immune response following virus infection. This gap in knowledge will be resolved by
answering the following questions: 1) How does mAR inhibit MHV infection? Does it inhibit the entry, RNA
replication, protein translation, assembly, or release of MHV? 2) What step(s) of the IFN induction pathway is
enhanced by mAR, and does mAR also affect the IFN response in bats, which are known to harbor many
highly pathogenic viruses? 3) What proteins are modified by PARPs following virus infection and which
substrates are relevant for specific phenotypes? The rationale for this research is that it will enhance our
understanding of mAR, including its ability to modulate protein function and will uncover novel cellular proteins
or processes that mediate virus replication. The work is innovative because: i) it will bridge a significant
knowledge gap between ADP-ribose biology, the innate immune response, and virus replication; ii) it utilizes
unique models of infection utilizing both mutant viruses and PARP knockout cells; and iii) will be the first to
address the role of mAR in bats. Finally, these projects are significant and relevant to the NIGMS mission
because they will provide a thorough understanding of how mAR impacts the anti-viral response that could lay
the foundation for advances in the treatment of virus infections or other human diseases impacted by mAR.
项目摘要
ADP-核糖基化是一种重要的翻译后修饰,其直接影响多个细胞的功能。
生物过程,包括癌症、过敏和传染病。ADP-核糖可以添加到蛋白质中,
一个或多个连续的单位由ADP-核糖基转移酶,也称为PARP,导致单-或多-
ADP-核糖基化(mAR或pAR)。病毒感染后,干扰素(IFN)可上调大多数马来酰化PARP。
感染和几个被预测具有抗病毒功能。此外,一些病毒家族,包括
冠状病毒科和披膜病毒科编码具有单ADP核糖基水解酶的大结构域蛋白
(ARH)活动这种活性使这些病毒能够特异性地抵消mAR的作用,进一步
表明mAR参与了哺乳动物的抗病毒反应。尽管有这些发现,
已知mAR抑制病毒复制的实例。这在很大程度上是由于缺乏细胞培养模型
在病毒感染中,细胞的mAR状态可以被特异性控制,例如使用突变体
病毒或具有显著表型的PARP敲除细胞。重要的是PI已经建立了一种病毒
使用模型冠状病毒,鼠肝炎病毒(MHV)的感染系统,其中缺乏ARH活性的病毒,
i)病毒复制显著受损,和ii)独立诱导强IFN应答。这些
表型被PARP抑制剂逆转,确立mAR为驱动这种抗病毒应答的关键因素。
研究者的长期目标是确定mAR如何在机制上抑制病毒复制,
增强病毒感染后的先天免疫反应。这一知识差距将通过以下方式得到解决:
回答以下问题:1)mAR如何抑制MHV感染?它能抑制RNA进入
MHV的复制、蛋白质翻译、组装或释放?2)IFN诱导途径的步骤是什么
增强mAR,mAR是否也影响蝙蝠的IFN反应,这是众所周知的港口许多
高致病性病毒3)病毒感染后PARP修饰了哪些蛋白质,
底物与特定表型相关?这项研究的基本原理是,它将提高我们的
了解mAR,包括其调节蛋白质功能的能力,并将发现新的细胞蛋白质
或介导病毒复制的过程。这项工作是创新的,因为:i)它将弥合一个重大的
ADP-核糖生物学、先天免疫应答和病毒复制之间的知识差距; ii)它利用
利用突变病毒和PARP敲除细胞的独特感染模型; iii)将是第一个
解决mAR在蝙蝠中的作用。最后,这些项目对国家地理测量系统的使命具有重要意义和相关性
因为他们将提供一个彻底的了解mAR如何影响抗病毒反应,
为治疗病毒感染或其他受mAR影响的人类疾病的进展奠定了基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anthony R Fehr其他文献
Anthony R Fehr的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anthony R Fehr', 18)}}的其他基金
Determining mechanisms of innate immune modulation by ADP-ribosylation
通过 ADP-核糖基化确定先天免疫调节机制
- 批准号:
10027966 - 财政年份:2020
- 资助金额:
$ 3万 - 项目类别:
Determining mechanisms of innate immune modulation by ADP-ribosylation
通过 ADP-核糖基化确定先天免疫调节机制
- 批准号:
10256655 - 财政年份:2020
- 资助金额:
$ 3万 - 项目类别:
Investigating How ADP-ribosylation Impacts Innate Immunity During Coronavirus Infection
研究 ADP-核糖基化如何影响冠状病毒感染期间的先天免疫
- 批准号:
9428897 - 财政年份:2018
- 资助金额:
$ 3万 - 项目类别:
Deciphering the Role of the Coronavirus Macro Domain in SARS-CoV Infection
破译冠状病毒宏结构域在 SARS-CoV 感染中的作用
- 批准号:
8781200 - 财政年份:2014
- 资助金额:
$ 3万 - 项目类别:
相似海外基金
Control of genomic integrity and virulence of Aspergillus fumigatus by ADP-ribosylation.
通过 ADP-核糖基化控制烟曲霉的基因组完整性和毒力。
- 批准号:
MR/X007472/1 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Fellowship
Understanding the impact of DNA ADP-ribosylation on telomere function in cancer cells
了解 DNA ADP-核糖基化对癌细胞端粒功能的影响
- 批准号:
10751121 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Composition and function of telomeric multi-protein complexes and their regulation by ADP-ribosylation
端粒多蛋白复合物的组成和功能及其ADP-核糖基化的调节
- 批准号:
2748032 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Studentship
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10524783 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Regulation of DNA repair by histone ADP-ribosylation
组蛋白 ADP 核糖基化调节 DNA 修复
- 批准号:
MR/W017350/1 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Research Grant
Regulation and function of site-specific protein poly-ADP-ribosylation
位点特异性蛋白质聚 ADP 核糖基化的调控和功能
- 批准号:
10668492 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
ADP-ribosylation of DNA in Mycobacterium tuberculosis
结核分枝杆菌 DNA 的 ADP-核糖基化
- 批准号:
BB/W016613/1 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
Research Grant
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10610165 - 财政年份:2022
- 资助金额:
$ 3万 - 项目类别:
A Chemical Footprinting Approach towards Poly-ADP-Ribosylation-regulated Biomolecular Condensation
聚 ADP 核糖基化调节生物分子缩合的化学足迹方法
- 批准号:
10389853 - 财政年份:2021
- 资助金额:
$ 3万 - 项目类别:
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
转录因子 ADP-核糖基化在乳腺癌生物学中的作用
- 批准号:
10593900 - 财政年份:2021
- 资助金额:
$ 3万 - 项目类别: